Figure 3
Mean difference in anatomical outcomes between intravitreal faricimab and control groups. (A) Central subfield thickness (µm). (B) Total CNV area (mm2). (C). Total lesion leakage (mm2).
Figure 3 | Scientific Reports
Mean difference in anatomical outcomes between intravitreal faricimab and control groups. (A) Central subfield thickness (µm). (B) Total CNV area (mm2). (C). Total lesion leakage (mm2).
